Related Experiment Video

Updated: Jul 19, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Disturbed assembly of human cerebral microtubules in Alzheimer's disease

P N Shevtsov1, E F Shevtsova, G Sh Burbaeva

  • 1Laboratory of Neurochemistry, National Center for Mental Health, Russian Academy of Medical Sciences. Ishev@ipac.ac.ru

Bulletin of Experimental Biology and Medicine
|September 21, 2006
PubMed

Insights

Researchers found that microtubular proteins from Alzheimer's disease brains can form abnormal microtubules in vitro. This discovery offers new insights into the structural changes occurring in the brain during Alzheimer's disease progression.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline.
  • Microtubules are essential components of the cellular cytoskeleton, crucial for maintaining cell structure and intracellular transport.
  • Abnormal protein aggregation is a hallmark of Alzheimer's disease pathology.

Purpose of the Study:

  • To investigate the in vitro polymerization behavior of microtubular proteins from Alzheimer's disease (AD) brains.
  • To determine if these proteins can form microtubules with aberrant structures.

Main Methods:

  • Isolation of microtubular proteins from post-mortem brain tissue of AD patients.
  • In vitro polymerization assays to induce microtubule formation.
  • Microscopic analysis (e.g., electron microscopy) to assess microtubule structure.

Main Results:

  • Microtubular proteins isolated from AD brains demonstrated the ability to polymerize in vitro.
  • The resulting polymerized structures exhibited abnormal morphology, deviating from typical microtubule architecture.
  • This is the first demonstration of in vitro polymerization of AD brain-derived microtubular proteins into structurally abnormal microtubules.

Conclusions:

  • The study provides direct evidence that microtubular proteins from Alzheimer's disease brains possess intrinsic properties leading to abnormal polymerization.
  • These findings suggest a potential mechanism contributing to microtubule dysfunction in Alzheimer's disease.
  • Further research into these abnormal structures may reveal novel therapeutic targets for Alzheimer's disease.

More Related Videos

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues07:21

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues

Published on: November 17, 2023

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Assembly of Complex Microtubule Structures01:32

Assembly of Complex Microtubule Structures

Complex microtubule structures are present in resting cells and in dividing cells. In resting cells, they are responsible for maintaining the cellular architecture, tracks for intracellular transport, positioning of organelles, assembly of cilia and flagella. They mediate the bipolar spindle assembly for chromosomal segregation and positioning of the cell division plate in dividing cells. The formation of microtubule complex structures depends on the cell type, cell stage, and cell function.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...